“…It is a common health condition worldwide with an estimated prevalence ranging from 11% to 31%, and is especially high in people with multiple sclerosis [ 3 , 4 ]. After a new episode of TMD, 27% of people persist with significant pain one year later [ 5 , 6 , 7 ], and recurrence is common [ 8 ]. Its related pain and disability bring direct (e.g., use of medication to alleviate symptoms) and indirect (e.g., productivity loss) costs [ 9 , 10 , 11 , 12 , 13 ]; therefore, effective management of the condition is important.…”